Superior Properties of Fc-comprising scTRAIL Fusion ProteinsMeike Hutt, Roland E. Kontermann, Lisa Marquardt et al.|Molecular Cancer Therapeutics|2017Cited by 38
IgG-single-chain TRAIL fusion proteins for tumour therapyMartin Siegemund, Roland E. Kontermann, F Schneider et al.|Scientific Reports|2018Cited by 28
Systemic network analysis identifies XIAP and IκBα as potential drug targets in TRAIL resistant BRAF mutated melanomaGreta Del Mistro, Dagmar Kulms, Philippe Lucarelli et al.|npj Systems Biology and Applications|2018Cited by 7
Supplementary Figure 6 from Superior Properties of Fc-comprising scTRAIL Fusion ProteinsMeike Hutt, Roland E. Kontermann, Lisa Marquardt et al.|Unknown|2023Cited by 0
Supplementary Tables S1-S5 from Superior Properties of Fc-comprising scTRAIL Fusion ProteinsMeike Hutt, Roland E. Kontermann, Lisa Marquardt et al.|Unknown|2023Cited by 0